GENEVA, Aug. 10 -- NUPHASE THERAPEUTICS (HANGZHOU) LIMITED., CO. (Room 1219, 21 Building, Hexiang Tech Center, Qiantang DistrictHangzhou, Zhejiang 310020), 抟相医药(杭州)有限公司 (中国浙江省杭州市钱塘区下沙街道和享科技中心21幢1219室) filed a patent application (PCT/CN2025/073388) for "BIOMACROMOLECULAR INTERACTION REGULATOR SCREENING PLATFORM BASED ON CONDENSATE DROP-FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING (DROP-FRAP)" on Jan 20, 2025. With publication no. WO/2025/162029, the details related to the patent application was publishe...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.